Does sacubitril/valsartan work in children with heart failure?—a pilot study
BackgroundSacubitril/valsartan is an angiotensin receptor neprilysin antagonist (ARNI) approved for adult heart failure (HF). Its safety and efficacy in pediatric HF patients with cardiomyopathy or congenital heart disease are poorly understood. A pilot study was conducted to assess the clinical res...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2023-11-01
|
| Seri Bilgileri: | Frontiers in Cardiovascular Medicine |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1274990/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|